Atlas Trials

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

Clinical trial NCT07555301 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07555301
Sponsor
Waid City Hospital, Zurich
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
IgA Nephropathy (IgAN)
Start date
2026-06-01
Primary completion
2028-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.